Pembrolizumab in Locally Advanced Sinonasal Carcinoma

Clinical trial NCT05925491 · RECRUITING

Trial details

NCT number: NCT05925491
Sponsor: Istituti Clinici Scientifici Maugeri SpA
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sinonasal Undifferentiated Carcinoma

Start date: 2024-12-24
Primary completion: 2026-12-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.